ArticleAmerican journal of preventive cardiology2026
Ten-year trajectory of Life's Essential 8 and aortic valve calcification.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The American Heart Association developed Life's Essential 8 (LE8) to improve the predictive ability of cardiovascular health (CVH). Aims: We sought to investigate whether a 10-year CVH trajectory is associated with the prevalence of aortic valve calcification (AVC), an early manifestation of calcific aortic valve disease (CAVD). Methods: The current study included 8047 participants who participated in the surveys at baseline (2006) and during follow-up periods (2008, 2010, 2012, 2014 and 2016). Repeated measurements of LE8 components including body mass index, cigarette smoking, diet quality, physical activity, sleep health, lipids, blood glucose and blood pressure, were used to construct the CVH trajectories. Ten-year CVH trajectory patterns from 2006 to 2016 were constructed using latent mixture models. AVC was diagnosed by echocardiography from 2016 to 2023. Results: During an eight-year follow-up period, 1005 AVC cases were identified. Compared to the moderate-decrease trajectory, the low-stable trajectory was associated with higher odds of AVC (odd ratio (OR): 1.46; 95% confidence interval (CI): 1.17, 1.83). Participants in the groups of moderate-increasing trajectory (OR: 0.78; 95%CI: 0.62, 0.98), moderate-stable trajectory (OR: 0.62; 95%CI: 0.52, 0.74), and high-stable trajectory (OR: 0.30; 95%CI: 0.20, 0.43) had lower odds of AVC compared with those in the moderate-decreasing trajectory group. The association between the CVH trajectory and AVC prevalence was more pronounced in men, younger individuals and those without chronic kidney disease. Conclusions: Maintaining or improving CVH was associated with lower odds of AVC. Our findings suggest optimizing CVH may provide a primordial preventive benefit against subclinical CAVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.